Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer.

ABSTRACT:

Background

Nomograms are rarely employed to estimate the survival of patients with advanced and metastatic pancreatic cancer (PC). Herein, we developed a comprehensive approach to using a nomogram to predict survival probability in patients with advanced and metastatic PC.

Methods

A total of 323 patients with advanced and metastatic PC were identified from the Chinese People's Liberation Army (PLA) General Hospital. A baseline nomogram was constructed using baseline variables of 323 patients. Additionally, 233 patients, whose tumors showed initial responses to first-line chemotherapy, were enrolled in the chemotherapy response-based model. 128 patients and 108 patients with advanced and metastatic PC from January 2019 to April 2021 were selected for external validating basel

SUBMITTER: Deng GC 

PROVIDER: S-EPMC8594118 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature